Hypoglossal Nerve Stimulator Implantation Safe for OSA in Children With Down Syndrome
By Elana Gotkine HealthDay Reporter
FRIDAY, Aug. 15, 2025 -- For children aged younger than 13 years with Down syndrome (DS) and severe obstructive sleep apnea (OSA), hypoglossal nerve stimulator (HGNS) implantation is safe and effective, according to a study published online in the September issue of the International Journal of Pediatric Otorhinolaryngology.
Minjee Kim, M.D., from Harvard Medical School in Boston, and colleagues conducted a retrospective cohort study at two academic institutions to examine the safety and efficacy of HGNS placement in children younger than 13 years of age with DS and severe OSA. The study included 29 children (median age, 10 years; 19 were male).
The researchers found that all children were safely implanted with no serious adverse events. One mild wound dehiscence occurred, which resolved with antibiotic ointment and pressure dressing; there were no adverse device effects. The median preop and postop obstructive apnea hypopnea index (OAHI) was 18.4 and 3.9, respectively. Twenty patients (95.2 percent) had an OAHI reduction of 50 percent or more at six months postop.
"This research has major implications, first being that the safety results can alleviate concerns about whether this procedure is possible in young children," coauthors Christopher Hartnick, M.D., from Mass Eye and Ear in Boston, and Brian Skotko, M.D., from Massachusetts General Hospital in Boston, said in a statement. "We also feel this research offers a message of hope to parents of young children with Down syndrome who have worried about their children’s sleep apnea."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.
Posted August 2025
Read this next
Blowing Conch Shell Tied to Improved Obstructive Sleep Apnea Measures
MONDAY, Aug. 11, 2025 -- Respiratory muscle training through shankh (conch shell) blowing improves outcomes in individuals with obstructive sleep apnea (OSA), according to a study...
CPAP Preferentially Improves Cardiovascular Outcomes in High-Risk OSA
WEDNESDAY, Aug. 6, 2025 -- In patients with high-risk obstructive sleep apnea (OSA), continuous positive airway pressure (CPAP) improves cardiovascular outcomes, while harm may be...
Obstructive Sleep Apnea Tied to Poor Outcomes in U.S. Soldiers
WEDNESDAY, July 9, 2025 -- Sleep disorders such as obstructive sleep apnea (OSA) contribute to mental health challenges, traumatic injuries, and increased health care utilization...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.